Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitis
Human Antibodies | March 6, 2017 | Volume: 25 | Issue: 3-4 | Pages: 121-129
10.3233/hab-170313
| PMID 28269761